Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.
Saved in:
| Title: | Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis. |
|---|---|
| Authors: | Palmer A; University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Rauscher G; University of Illinois at Chicago School of Public Health, Chicago, IL, USA., Schoen A; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Burkart M; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Dunton A; Department of Medicine, Rush University, Chicago, IL, USA., Au C; Department of Medicine, Rush University, Chicago, IL, USA., Dave A; Atrium Health Levine Cancer Institute, Chicago, IL, USA., Nassar A; Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA., Zhu S; University of Illinois College of Medicine, Chicago, IL, USA., O'Hara A; Department of Medicine, Loyola University Medical Center, Chicago, IL, USA., Africawala N; Loyola University Stritch School of Medicine, Chicago, IL, USA., Erra A; Department of Hematology Oncology, Northwestern Medical Group, Chicago, IL, USA., Solipuram V; Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA., Abraham I; University of Chicago Medicine, Chicago, IL, USA., Tsai SB; Division of Hematology and Oncology, Department of Medicine, Loyola University Medical Center, Chicago, IL, USA., Zia M; Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA., Larson ML; Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL, USA., Rondelli D; Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA., Altman JK; Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Stock W; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA., Khan I; Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Odenike O; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA., Patel AA; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. anand.patel@bsd.uchicago.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Oct 06; Vol. 15 (1), pp. 158. Date of Electronic Publication: 2025 Oct 06. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01366-x |
